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Abstract We present CoSMoS as a way of structuring think-
ing on how to reuse parts of an existing model and simula-
tion in a new model and its implementation. CoSMoS pro-
vides a lens through which to consider, post-implementation,
the assumptions made during the design and implementa-
tion of a software simulation of physical interactions in the
formation of vascular structures from endothelial cells. We
show how the abstract physical model and its software im-
plementation can be adapted for a different problem: the
growth of cancer cells under varying environmental pertur-
bations. We identify the changes that must be made to adapt
the model to its new context, along with the gaps in our
knowledge of the domain that must be filled by wet-lab ex-
perimentation when recalibrating the model. Through pa-
rameter exploration, we identify the parameters that are crit-
ical to the dynamic physical structure of the modelled tissue,
and we calibrate these parameters using a series of in vitro
experiments. Drawing inspiration from the CoSMoS project
structure, we maintain confidence in the repurposed model,
and achieve a satisfactory degree of model reuse within our
in silico experimental system.
Keywords calibration · CoSMoS ·model reuse · simulation
1 Introduction
The CoSMoS process (Andrews et al, 2010; Stepney et al,
2015) describes a principled approach to scientific modelling
and simulation: it provides a structure for managing and
documenting the iterative development of a simulation, and
gives scientists and simulation developers tools to reason –
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with an appropriate balance of confidence and scepticism
– about how their simulation’s results relate to the domain
of study. CoSMoS is an agile approach to support develop-
ment of models and simulations of complex systems: a user
may organise their project entirely following the CoSMoS
principles, or they may integrate some of the CoSMoS pro-
cess as appropriate into an existing project. In brief, CoS-
MoS identifies, among others, the following concepts: (1)
Research Context, which notes the high-level motivations
and hypotheses; (2) Domain, the subject of scientific re-
search; (3) Domain Model, defining the purpose, scale and
scope of the simulation activity; (4) Platform Model, an en-
gineering derivation of the Domain Model; (5) Simulation
Platform, an encoding of the Platform Model; and (6) Re-
sults Model, capturing understanding of the simulation based
on output.
Reusability of software components is a key concern of
software engineering. Reusable components can – ideally
– avoid the difficulty and expense of developing and val-
idating substantial amounts of new software. But software
developed for one purpose may not be reusable for a differ-
ent purpose without substantial modification. In particular,
a simulation component developed for one in silico exper-
iment may rely on assumptions (parameter values, model
simplifications, etc.) that are only valid within the context
of that experiment. Adapting such a component for reuse in
a different context requires careful consideration of the as-
sumptions made during its design. In this paper, we use the
general structure of the process of modelling and simulat-
ing complex systems as considered by CoSMoS to organise
our thinking around how a model of physical interactions
among cells can be adapted from one context – the formation
of vascular structures from endothelial cells – to a different
context, that is the effect of anti-cancer drugs on the growth
of cells in in vitro systems. Neither of these projects was
initially developed using a CoSMoS approach. To apply the
2 Ye Li et al.
CoSMoS process, we must first effectively reverse-engineer
our work to date, and attempt to organise the information we
have about the systems under study and our models and sim-
ulations of them broadly in terms of the CoSMoS concepts
(1) to (6) as listed above. We expect that this step in itself
will prove valuable.
Our objective is specifically to reuse the software com-
ponents that implement the physical aspects of the model
of vascular formation, referred to as Model 1, within the
implementation of the model for cell growth, referred to
as Model 2, since this implementation required consider-
able development effort and are critical to the overall per-
formance of the simulation. As the modes of physical in-
teraction among cells are broadly similar between Models 1
and 2, this seems intuitively to be an appropriate approach –
but identifying and revalidating our assumptions will help to
build our confidence in our simulation’s results, and enable
the future reuse of the implementation of physical aspects of
cell interactions in other contexts. In respect of this, we use
CoSMoS to guide our reuse.
In addition, we have domain expertise in the field of
cell biology and have conducted wet-lab experimentation
studying the growth of cancer cells in response to perturba-
tion by the therapeutic drug 5-fluorouracil (5-FU), hypoxia
(oxygen deprivation) and the combination of both effects.
Importantly, under hypoxic stress cells can respond differ-
ently to therapeutic intervention (Papageorgis et al, 2011).
We present a new model, Model 2, of the cell and its re-
sponse to anti-cancer drugs and hypoxia, and identify those
components of Model 1 that can be reused in the imple-
mentation of Model 2. We then fit Model 2 to the experi-
mentally measured cell growth rate in our control condition:
this serves as the baseline calibration. We then determine
the in silico changes we need to make to reproduce other in
vitro experimental conditions, specifically the effects of 5-
FU and hypoxia as single interventions, and these changes
are linked to plausible biological mechanisms. Finally we
test the amended model against other experimental data de-
scribing the effect of 5-FU and hypoxia in combination.
The paper is structured as follows. Sect. 2 describes the
original model (Model 1) of vascular structures. We describe
the model through CoSMoS concepts as a structured means
to report on the model context, assumptions, results and so
on. In Sect. 3 we describe Model 2 using the same step-
wise, CoSMoS structured approach to lay out the new re-
search context, domain, etc. in order that we can expose
those parts of the original vascular structure model that may
be re-used and those that may not, together with new addi-
tions required. In this way, CoSMoS is used as a framework
to support model reuse. In Sect. 4 we describe our first ef-
forts in using the new model to understand cellular response
to therapeutic insult and environmental stress.
2 Model 1: Vascular Formation
2.1 Research Context
Mammalian cells require blood vessels to deliver oxygen
and other nutrients in order to survive. Capillaries are made
up of endothelial cells and one of the key elements that
drives their growth is growth factor VEGF (Karamysheva,
2008). We seek to build a model to understand not only the
range of structures that endothelial cells can form but also
the process by which those structures are formed. We will
then compare simulation results with the results of an in
vitro experiment from the literature, demonstrating the for-
mation of capillary structures from endothelial cells (Serini
et al, 2003).
The experiments by Serini et al (2003) explore how the
physical interactions among the cells, and their low-level
physical properties, affect the larger-scale structural patterns
in the resulting capillary network. The effects of varying
concentrations of growth factors – which have a direct ef-
fect on the low-level physical properties of the cells – are of
particular interest.
2.2 Domain
The vascular system is complex and made up of various
kinds of cells, and it grows in three dimensions (Cavalli et al,
2007). We seek to simplify the study of vascular formation
and study the behaviour of endothelial cells and their inter-
actions. It is challenging to study vascular formation in three
dimensions, and experimental studies have explored this in
in vitro systems in two dimensions (Gamba et al, 2003). We
start from the position of in vitro capillary formation ex-
periments: endothelial cells are planted on a substrate and
self-organise to form capillaries; note we recognise the pro-
cesses of capillary formation may differ in vivo (Karamy-
sheva, 2008). In the in vitro experiment, microvessels are
formed by the aggregation of endothelial cells, which them-
selves are formed by the differentiation of stem cells. This
formation process has three stages (Folkman and Hauden-
schild, 1980; Cavalli et al, 2007):
– cell migration and early network formation;
– network remodelling, where cells connect to each other;
– further differentiation into tubular structures.
For the purposes of this experiment, we are only con-
cerned with the first stage, which takes place between six
and nine hours in vitro (Serini et al, 2003). At the end of this
stage, the basic network structure has formed, but cells have
not yet begun to bind to each other or to differentiate fur-
ther. All cells are similar in general terms during this stage,
although their individual properties may vary.
Understanding tissue morphology: model repurposing using the CoSMoS process 3
We believe that in this stage the most significant forces
are those resulting from physical interactions: between pairs
of cells, between cells and their surrounding medium (Batch-
elor, 2000; Szabó et al, 2011), and between cells and the
substrate, Matrigel film (Serini et al, 2003, p. 1778). As the
surrounding medium is relatively thin and the interactions
with the substrate are strong, there is only limited potential
for cell movement away from the substrate, and experiment
imaging can be used effectively to capture cell positions
in real-world systems. Time-series imagery can be used to
characterise cell interactions – for example, Niles (2012)
shows physical interactions among stem cells in vitro, in-
cluding attraction between cells, and cell shape changes af-
ter differentiation and binding.
As cells follow growth factor gradients, the density of
cells tends to be higher where there is a higher concentra-
tion of growth factors in the environment. The in vitro ex-
periment examined the effects of an artificial reduction of
growth factor levels across the environment, imaging con-
trol and reduced-factor experiments at 3 h intervals.
2.3 Domain Model
Within the Domain described in Sect. 2.2 we wish to study
the dynamics of interactions of endothelial cells in vitro.
This requires us to consider the cells as individual, inter-
acting agents and we limit those interactions to inter-cell
physics. We must build in a substrate on which cells grow
and this substrate must include a growth factor to promote
cell movement – cells follow growth factor gradients and
this makes possible cell aggregation including but not lim-
ited to vascular formation (Karamysheva, 2008). We are only
interested in simulating the first phase of vascular formation
and during this time the total number of endothelial cells
does not change (Serini et al, 2003). Thus it is reasonable to
assume endothelial cells do not die or divide in the in vitro
experiment. We do not therefore need to simulate cell differ-
entiation or the cell cycle. Further, cells do not measurably
change their size or shape over this time period.
Fig. 1 shows the entities within the in vitro experiment
that we are attempting to reproduce, and their interactions.
This includes both the biological entities under study and
their experimental environment. Vascular structures are also
included here as an emergent behaviour of the cells. Note
that we have used UML-style diagrams in a rather informal
way throughout our description, using familiar syntax but
adapted semantics – for example, while growth factors are
indeed individual molecules, it would clearly be inappropri-
ate to think about them that way when modelling the system.
Such diagrams are still useful as “cartoon models” (Étienne,
2006), capturing our (necessarily limited) understanding of
the system in a convenient but loosely-specified notation.
Ellipsoid
Substrate
SimulationWorld
growthFactor
applies forces
applies forces
position
direction
geometry
Fig. 2 Platform model: the entities of concern in the simulation, shown
as a class diagram
2.4 Platform Model
Existing discrete models of capillary formation can be di-
vided to two types (Welter et al, 2009): those that consider
cells as continuous density distributions, e.g. Holmes and
Sleeman (2000); and those that consider cells as individual
agents moving on a lattice, e.g. Turner and Sherratt (2002).
We choose to consider cells as agents with particular shapes
and seek to assign the same rule to all agents to reproduce
the vessel structure as an emergent behaviour. However we
will let the agents move in continuous space rather than
a discretised environment. In this way we hope to capture
more detailed cell movement, so that as a result we will have
a better understanding of the vessel formation process, not
only the vessel structure.
Fig. 2 gives an overview of how the domain model has
been simplified for the purposes of the simulation. Cells
show a direct correspondence between the domain and plat-
form models. This allows us to define interacting rules for
single agents, and examine both the lower-level properties of
individual agents and the higher-level behaviour of the sys-
tem as a whole. The simulation proceeds in discrete timesteps,
with all agents updating their positions and orientations atom-
ically at the end of a timestep.
Vascular structures are not represented in the Platform
Model since these are the emergent property that we are at-
tempting to reproduce. The Domain Model has been sim-
plified to allow implementation of the physical interactions
within the system as described below.
While cells can take a wide variety of shapes in the real
world, we must model these as simpler shapes in order to
practically simulate physical interactions at realistic scales.
Modelling cells as simple spheres simplifies reasoning, but
it does so by discarding information about the orientation
of the cell, which limits the types of physical interactions
that are possible. Initial prototyping showed that it was not
possible to reproduce vascular formation behaviour using
spheroid agents. Instead of forming the net-shaped structure,
the spheroid agents form separate clusters.
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VascularStructure
physically 
interacts with
physically 
interacts with
forms
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Fig. 1 Domain model: the entities of concern in the domain, shown as a UML-style class diagram
torque torque
force
Fig. 3 Idealised ellipsoid agents within the platform model, showing
torque and force
We therefore represent cells as ellipsoids (Fig. 3). The
shapes of cells observed in the in vitro experiment by Serini
et al (2003) are roughly ellipsoidal (in the first phase), and
previous models have assumed that ellipsoids are an appro-
priate representation of cell shape, e.g. Palsson (2001). An
ellipsoid has three orthometric semi-axes, which can be used
as a local coordinate system. The rotation of an ellipsoid can
be represented by the change of this local coordinate sys-
tem, and the direction of an ellipsoid can be represented by
the transformation from the local coordinate system to the
global coordinate system. The position of the centre of an
ellipsoid represents the position of the whole ellipsoid. For
simplicity we assume all the agents have the same size and
shape.
We assume that the density of agents is evenly distributed,
so forces can be modelled as acting on the centre of the
agent, and changes in agent orientation can be modelled as
torques acting on the agent. This is a modelling convenience
and difficult to validate against experimental data, as cell ro-
tations are hard to distinguish in time-series images.
We model physical interactions between cells in terms of
forces between agents. The adhesion force attracts agents to
each other; the contact force repels them and prevents them
from overlapping; there is also a resistance force resulting
contact force
cell
potential surfaces
Fig. 4 An ellipsoidal agent showing potential surfaces, and the vector
along which contact force is computed
from agents’ interactions with the surrounding medium. For
each force, there is an corresponding torque that is computed
in an analogous way.
The contact force only takes effect when agents are in
physical contact; the greater the overlap, the greater the con-
tact force. It is introduced to prevent agents from totally
overlapping. As the ellipsoid is not an isotropic shape, we
cannot simply use the distance between two ellipsoids to cal-
culate the contact force and torque. Instead, we compute a
potential for each interaction: a path-independent potential
energy. In Fig. 4, dotted lines represent potential surfaces
around the agent – the potential is constant for any point on
the same surface, although the distance to the agent centre
will vary as a result of the agent shape. The potential is cal-
culated following the approach given in Perram et al (1996),
using the direction, position and length of the semi-axes of
the interacting ellipsoids.
The potential is then transformed into energy using the
Hertz formula. The magnitude of the resulting force or torque
is the same for all points on a potential surface; the direction
is computed based on the partial derivative of the energy
field towards the centre of the interacting ellipsoid (Fig. 4).
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cell
mirrorsubstrate
Fig. 5 Agent-substrate interaction, modelled as interaction with a copy
of the same agent, mirrored in the substrate plane
The growth factor is considered to be a key factor in en-
dothelial cell activation in vitro (Karamysheva, 2008). We
model this mechanism as an adhesion force between agents,
which is modelled as a constant force attracting the cen-
tres of every pair of agents towards each other. This is the
simplest approach that reproduces the behaviour observed
in time-series images of the in vitro experiments. However
early prototyping showed that the vessel structure was not
stable due to interactions between far away agents, so that
we must limit the distance that the adhesion force can take
effect: if agents are beyond this distance they have no physi-
cal interactions; if they are within range, they move towards
each other, until they become close enough to overlap, stop-
ping at the point at which the adhesion force and contact
force balance each other.
The relative strengths of the two forces may be cali-
brated so that this balance happens at a potential correspond-
ing to that observed in cells in vitro. Unlike real cells, our
agents cannot change their shape on contact. Yet we still
need to model the elasticity of the real cell. The potential
of this balancing point can be considered as the elasticity of
the agents, with higher balancing potential levels indicating
more rigid agents. Some elasticity is necessary to obtain re-
alistic cell interactions: an early prototype of the model used
a simpler approximation to the Hertz function which effec-
tively gave inelastic collisions between agents, and resulted
in agents visibly “bouncing off” each other – which did not
match what we see in time-series images.
As cells move at relatively low speeds within the medium,
according to classical mechanics (Goldstein et al, 2001) their
acceleration can be approximated as zero – which means the
sum of the forces upon them is also zero:
∑F = 0 = Fcontact +Fadhesion +Fresistance (1)
We can therefore compute the resistance force in terms of
the contact and adhesion forces – and, from this, compute
the velocity of the agent using Stokes’ law, based on the
known size and shape of the agent and the properties of the
medium. The angular velocity can be found using a simi-
lar technique; from these, the position and orientation of the
agent on the next timestep can be computed.
The substrate itself is modelled as a plane. The physical
interaction between an agent and the substrate is modelled
as the interaction between an agent and its mirror image in
the plane (Fig. 5). Having observed that cells generally move
in the plane of the substrate and do not grow on top of other
cells under in vitro experimental conditions, we assume that
the interactions between cells and the substrate are stronger
than between cells and other cells. Therefore the adhesion
force between an agent and its mirror image is scaled up to
account for that.
The model is dimensionless, being defined in terms of
a unit time (the simulation timestep) and a unit length (the
radius of a typical agent). These two quantities are related,
in that computing the velocity of an agent within the fluid
medium depends on both the timestep and the shape of the
agent. However, making an assumption about the maximum
velocity of an agent allows us to find reasonable bounds for
one unit knowing the other, and in our case choosing a unit
timestep of 1 s gives a physically-plausible maximum veloc-
ity for endothelial cells.
2.5 Simulation Platform
The simulation is implemented by a program written in C++
in line with the assumptions and detail described in the plat-
form model (Fig. 2). On program start up, the Simulation
World initialises a set of agents and a plane that represents
the substrate. According to the geometry definition of an el-
lipsoid, each agent is assigned with a random position within
the range of the plane, as well as three orthometric direc-
tions for the three semi-axes. The lengths of the semi-axes,
however, are fixed in the proportion 1 : 1 : 4. In this way, all
the agents are identical with random position and direction.
Typically there are 2000 to 4000 agents in one simulation.
After initialisation, the Simulation World enters a loop
in which it calculates the forces and torques for agents, up-
date their position and direction, and outputs the geometry
data to text files. This loop repeats for the desired period of
simulated time. Visualisation and analysis are carried out by
external tools.
In each loop, the simulation goes through all the agents.
For each agent, the Simulation World calculates the overall
force and torque that other agents work on this agent, then
calculates the force and torque between this agent and the
plane. The rules to calculate the force and torque are de-
fined within the agent object, so that the program may sim-
ulate emergent behaviours of a heterogeneous population of
agents without changing the behaviour of the simulation rule
set.
The Simulation World then estimates the total force and
torque on the agent, thereby estimating the velocity and an-
gular velocity of the agent, and uses these values to deter-
mine the new position and direction of the agent.
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Fig. 6 Visualisation showing agent positions and orientations at the
start (left) and end (right) of the simulation; “unstable” pattern
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Fig. 7 Radial distribution of agents in Fig. 6 (right); X axis is distance
between agents in simulation units, and Y axis is normalised probabil-
ity of finding another agent at that distance
The position and direction information of all the agents
are stored regularly into text files, resulting in a time-lapse
record of the geometric information of all the agents. A vi-
sualisation program (Zhu et al, 2006) reads these text files in
the same order, and produces 3D imagery using the OpenGL
framework to render the agents as ellipsoids. When the visu-
alisation program is running, we have the ability to observe
the agents at an arbitrary distance and at an arbitrary angle.
However for further study, we must save the scenario as im-
ages, in which the angle of observation is fixed. To best vi-
sualise the overall vessel structure, we choose the top-down
angle. In each image, to separate agents and the plane, they
are drawn with different colours: the agents are in green and
the substrate is in blue.
As there are thousands of agents and a large amount of
calculation, a full simulation would take up to 6 days to run
on a single core. We made use of the Threading Building
Blocks library (Reinders, 2007) to parallelise the simulation,
achieving good parallel speedup.
2.6 Results Model
Fig. 6 shows the starting and ending conditions of the simu-
lation. This certainly resembles the vascular network we are
trying to reproduce – but we need a quantitative measure of
this, in order to relate the results back to the changes in the
level of growth factor.
There is a quantised method to describe the pattern of
this structure, which is called the radial distribution func-
tion. The radial distribution function is a tool to describe
space distribution of a system that consists of particles (here
agents), by describing the chance of finding another parti-
cle within an arbitrary distance from the reference particle.
In the form of the distribution curve, normally the X axis is
distance, and the Y axis is the function value. If the function
value is larger than 1.0 at a certain distance, it means the
agent density is higher than average at that distance; if the
function value is smaller than 1.0, it means the agents are
more sparse at this distance. Fig. 7 shows the radial distribu-
tion of agents at the endpoint of the simulation.
The minimum near distance 0 shows that agents tend not
to have very close neighbours; the second minimum near
distance 25 shows the typical size of hole in the net-shaped
structure. As the distance from the reference agent increases,
the value of the distribution function varies around 1.0, which
means over longer distances the agents tend to be distributed
evenly. We observe that our simulation based on physical in-
teractions yields broadly similar results to those that Serini
et al (2003) demonstrated using a model based on growth
factor.
If we allow the simulation to continue past the state shown
in Fig. 6 – i.e. past the period of time covered in the origi-
nal model design – the pattern will collapse into a few large
clusters of agents. Fig. 8 shows the results of an simulation
where the physical parameters have been adjusted to pro-
duce a stable pattern that does not collapse; while some net-
work structure is evident, these structures are formed at the
scale of the individual cells. This scale reduction is evident
in Fig. 9: the sharply-defined minimum around distance 12
(1.5 cell lengths), which corresponds to the typical vascular
net size. We also see a more pronounced double peak result-
ing from cells positioned end-to-side (with cell centres 0.5
cell lengths apart) and end-to-end (1 cell length apart).
The validation of the model requires more work, but now
we can show that the physical interactions among individual
agents are linked to the emergent group pattern: by changing
the physical parameters of individuals we can control the
emergent structure. The simulation components relating to
physical interactions are the parts that are most likely to be
reused in Model 2, with the broader code structure noted in
Sect. 2.5 that supports reuse with minimum changes.
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Fig. 8 Visualisation showing agent positions and orientations at the
start (left) and end (right) of the simulation; “stable” pattern
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Fig. 9 Radial distribution of agents in Fig. 8 (right); X axis is distance
between agents in simulation units, and Y axis is normalised probabil-
ity of finding another agent at that distance
2.7 Summary
Following the outline of the CoSMoS process, we have char-
acterised Model 1 in terms of a set of assumptions that may
affect reuse of the model. The assumptions (with their asso-
ciated CoSMoS modelling phases) are:
– Only contact force, adhesion force and resistance force
are significant (Domain).
– Cell size and shape do not change during the experiment
(Domain Model).
– Cells do not divide or die during the timeframe of our
experiment (Domain Model).
– Cells can be implemented as ellipsoids (Platform Model).
– Matter is evenly distributed within a cell (Platform Model).
– Contact force can be computed using the Perram-Wertheim
approach (Platform Model).
– Adhesion force can be modelled as a step function on
distance (Platform Model).
– Contact and adhesion forces balance at a defined point
when cells are in contact, and the strengths of the forces
can be calibrated based on this (Platform Model).
– Cells move at very low speed so their acceleration ap-
proaches zero and the forces upon them are balanced
(Platform Model).
– Resistance force can be computed using Stokes’ law,
and the known properties of the fluid medium (Platform
Model).
– Interactions with the substrate can be modelled as inter-
actions with mirrored agents (Platform Model).
3 Model 2: Towards Spheroid Growth
Model 2 is also presented via the CoSMoS process. Clearly
the research context is different, and so differences will cas-
cade through all of the modelling phases. Despite this, both
research contexts consider mammalian cells interacting in
space over time. This commonality may offer an opportu-
nity for code reuse from Model 1, and we use CoSMoS to
help us structure our thinking on the reuse of code.
3.1 Research Context
As with the vascular development model (Model 1), our ob-
jective is to relate lower-level physical interactions to higher-
level structural behaviours: specifically, we want to explore
the effects of
– certain cancer treatment drugs,
– hypoxia (low concentrations of oxygen), and
– different cell lines (types of cell grown for experimental
purposes)
upon the growth of cancer cells in general and tumours in
particular. This work forms part of a wider programme of ac-
tivity developing techniques for cancer drug discovery and
development (Bown et al, 2012). Our domain experts are
cancer researchers who are interested in making use of mod-
els and simulations to direct experimentation.
Tumours develop distinctive patterns of cells, which can
be classified by domain experts either manually or using au-
tomated image processing. Indeed medical pathology relies
heavily on this patterning as an indicator of disease progres-
sion and prognosis. It is specifically these kinds of spatial
patterns that we are interested in reproducing within a sim-
ulation.
Our existing physical model (Model 1) has already demon-
strated the ability to reproduce spatial patterns of cell growth
resulting from physical interactions within an agent-based
simulation, and we have existing tools to visualise and anal-
yse output from the model. We would like to reuse as much
of this infrastructure – both the model and the simulation
code – as possible to reduce development time, but to do
this we must identify the changes that need to be made by
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Fig. 10 2D side-view image of a three-dimensional spheroid growing
within a gel medium
re-evaluating our original assumptions within the new re-
search context.
In addition, we must identify what information neces-
sary for reengineering and calibrating the model needs to be
obtained by wet-lab experimentation. We aim to maximise
the value obtained from this experimentation.
3.2 Domain
In the real-world domain, cancer cells develop and grow
into tumours within surrounding tissue (Brú et al, 2003).
In laboratory conditions, growth experiments are limited to
populations in a Petri dish – in which case cells can grow
as a monolayer of cells on a substrate – or be suspended
in a volume of gel, in which case spheroid structures can
form (Fig. 10). Such spheroid systems provide 3D systems
of cell cultures that are closer to the real system than 2D
Petri dishes in terms of cellular response to drug action –
see Kimlin et al (2013) for review. We have worked on 3D
systems ourselves (Savage et al, 2013) and recognise both
the value of 3D systems and the difficulties working with
these systems. As noted by Kimlin et al (2013) an in vitro
three-dimensional tissue model is not yet the standard but
will play an increasing role in the drug discovery process in
due course.
Petri dish experiments are the current standard since they
are easier to configure, control and collect data from, since
images can be taken non-destructively; spheroids must be
sectioned before imaging in order to obtain data at a cellu-
lar resolution. A typical Petri-dish experiment may contain
around 103 cells; a spheroid contains on the order of 106
cells. A single section through a spheroid is comparable in
size to a Petri-dish experiment.
As a first step we are modelling Petri dish experiments
although our ultimate goal is to work with spheroid struc-
tures. Our Petri dish experimental system has three impor-
tant features that serve as a platform for spheroid modelling:
we are using cells (cell line HCT116) that will cluster into
a spheroid; we are using a therapeutically relevant drug; we
are exploring the impact of hypoxia, i.e. oxygen stress and
this is experienced by cells inside the spheroid.
The shape and volume of cells varies as they progress
through their developmental cycle (Fig. 11) and the rates at
which the cycle progresses vary somewhat among cell lines.
The HCT-116 cells we are using (human colorectal cancer
cells; see Sect. 4.1 for details) typically have diameter 10 μm
immediately after division. Our experimental setup allows
time-lapse imaging of cell growth and division at 10 min
intervals. The maximum length of an experiment is con-
strained by cells only remaining healthy under experimental
conditions for a limited period of time.
Some cancer drugs limit cell growth by arresting the cell
cycle at a particular stage (Morgan, 2007). The progression
of the cell cycle within the individual cells is therefore im-
portant when understanding the effects of drugs upon a tu-
mour: if the cell cycles are synchronised (as can happen un-
der in vitro and in silico conditions), then a drug can arrest
many cells simultaneously, whereas cells at a mix of devel-
opmental stages will be less strongly affected.
For in vitro spheroid structures and in vivo tumours, we
are particularly interested in the effects of hypoxia, which
can have a suppressive effect on cell growth (Kaida and
Miura, 2012). The high density of cells within a 3D tissue
structure means that cells become increasingly hypoxic to-
wards the centre of that structure.
3.3 Domain Model
Fig. 12 shows the entities within the domain model. While
the domain is substantially different from the previous one,
the way cells are modelled retains a level of similarity, be-
cause the emergent behaviour of interest still results from
physical interactions among cells. However, the physical prop-
erties of the cells themselves are somewhat different from
our previous model – in particular, the cells’ properties are
known to change over time, and we are interested in the ef-
fects of this on the emergent properties.
The main difference from Model 1 is that in order to
capture the effects of drug action and hypoxia we must in-
troduce a cell cycle. The cell cycle is the process by which
the cell grows, replicates through division and dies. It com-
prises several phases that happens in a specific order. Fol-
lowing cell division cells are in G1 phase in which a cell
increases its size. During phase G1 the cell may switch to
and from phase G0 – a resting phase. To progress beyond
G1, the cell is required to pass a G1 check point before en-
tering the next phase in the cell cycle. The next phase after
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Fig. 11 HCT-116 (p53+/+) cells, imaged at 0 h, 6 h, 12 h and 18 h of growth on a glass plate. The diameter of the initial cell is 10 μm.
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Fig. 12 Domain model: the entities of concern in the domain, shown as a class diagram
the G1 check point is the synthesis phase S in which DNA
replication occurs. Then the cell enters phase G2 and con-
tinues to grow. The cell is next required to pass a G2 check
point before entering the mitosis (nuclear division) phase M,
in which cell growth is stopped. A check point in the middle
of phase M ensures that the cell is ready for division. The
cell divides right after phase M into two daughter cells that
contains roughly equal cellular components. The cell apop-
toses if it fails to finish the cell cycle within a limit amount
of time (Karamysheva, 2008).
The drugs and hypoxia conditions are added to our envi-
ronmental conditions. They each impact the cell cycle pro-
gression differently. For the two-dimensional experiment,
we still need to consider the substrate. But for the spheroid
experiment, as the tumour cells grow in 3D in agar gel, we
will no longer consider the substrate.
3.4 Platform Model
We established in the domain model that the individual de-
velopment of the agents – e.g. the growth of cells over time
– will be important to the behaviours we are trying to repli-
cate, and must be taken into account in the simulation. As
a result, we have chosen again to use an agent-based mod-
elling approach. Fig. 13 shows the entities within the simu-
lation platform. Comparing to the platform model of Model
Ellipsoid
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SimulationWorld
oxygenConcentration
drugConcentration
applies forces
applies forces
age
cycleState
extents
position
direction
geometry
Fig. 13 Platform model: the entities of concern in the simulation,
shown as a class diagram
1, vascular formation, it is clear that the age, cell cycle state
and cell extents are newly added into our ellipsoidal agent,
and the oxygen concentration and drug concentration are
newly added to the simulation world, while the growth fac-
tor is removed from the simulation world.
Fig. 14 shows the state machine that models a simplified
cell cycle and drives the behaviour of the simulated agent.
This represents the observed behavioural modes of the cell –
growth, reproduction, apoptosis – rather than the biological
markers that would normally be used to describe cell cycle
stages. We model the resting phase G0 as the Idle state, from
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Fig. 14 Platform model: simplified cell cycle, shown as a state diagram
which the cycle of the agent starts. The growth phases G1,
S and G2 are modelled as the Growing state, during which
the agent doubles its size. As we hope to focus on the spatial
structure formed by the agents, we simplify the cell growth
dynamics and will consider the change of agent size and
shape only.
As introduced in Sect. 3.2, a cell may switch between
phase G0 and G1 repeatedly. This behaviour is modelled
as unlimited switching between the Idle and Growing state.
The phase is not retained in our model, because the size of
the agent is considered as constant in this phase. We model
all check points together as one single state – the Dividing
state, in which the agent decides whether to divide into two
identical agents or to die. An agent enters the Dividing state
when it doubles its volume, or is forced to by environmental
conditions. The probability that one agent successfully di-
vides is determined by the type of cell the agent represents
and the environmental conditions. The process of death of
agent is also simplified. If an agent dies it will be moved to
the Idle state and is then deleted.
We introduce typical age which is the time period that an
agent may exist and this represents the length of cell cycle
(of a real cell). The total time an agent exists is recorded, and
when it reaches the typical age, the agent will undergo the
process of death. The value of typical age will be calibrated
using in vitro data since this varies across cell types. The
mechanism of action of our perturbations of drug interven-
tion and hypoxia will take effect on these simplified states.
An agent not affected by any environmental condition will
start from the Idle state, then switch to the Growing state
and remain there until it doubles its volume, then either di-
vide to two identical agents or die. However, a perturbation
may alter the probabilities of transitions between states.
In the construction of the physical aspects of this plat-
form model, we aim to reuse, as far as possible, our previ-
ous approach. In order to evaluate whether this is appropri-
ate, we must reconsider our previous assumptions, listed in
Sect. 2.7, based on our knowledge about the new research
context.
While the physical properties of the cells and medium
are somewhat different, we propose that most assumptions
remain valid (see Sect. 3.7 for a summary). Two assump-
tions, however, are no longer reasonable: cell size and shape
do change during the simulation. This requires changes to
how the interaction potentials and their resulting forces and
torques are computed, since these must now take changes to
cell size and shape into account.
We must also ensure that we have sufficient experimen-
tal data to allow calibration of the physical parameters. We
no longer just need the typical size and shape of a cell: we
need a profile of how cell size and shape can change as the
cell cycle progresses. This information will need to be ob-
tained by time-series imaging under the experimental con-
ditions we wish to simulate, as in Fig. 11. We will then give
each simulated cell an interpolated cell growth curve relat-
ing cell size to time based on the measured points. The other
information we need for calibration is available in the liter-
ature (e.g. the dynamic viscosity of the medium).
The choice of timestep size (i.e. unit time in the model)
is a concern. The timestep must be short enough to obtain
results at a comparable temporal resolution to the in vitro
experimental data. However, smaller timesteps require more
calculation steps to simulate the same length of real-world
time; the 1 s timesteps used in the previous simulation would
result in in silico experiments taking an impractically long
time to run with typical simulation sizes of 103–106 cells.
In the in vitro experiment described in Sect. 4, the typ-
ical treatment time is 48 h to 72 h, and the sampling rate
varies with different phrases of the experiment. The total
number of cells is measured every 24 h and a time-lapse im-
age is taken every 10 min for the first 20 h of treatment. The
simulation timestep does not therefore need to be any less
than 10 min, and 1 h is assumed to be reasonable. The other
model constants will need to be adjusted to suit this time step
– for example, this results in the simulation’s unit length be-
ing considerably smaller (which does not affect the outcome
of the simulation).
3.5 Simulation Platform
The Simulation World initialises the agents at program start
up. As discussed in Sect. 3.4, each agent is assigned a typ-
ical age, which is estimated by observing the length of the
in vitro cell cycle in time-lapse images. However the initial
simulation produced a staircase-shape growth curve which
is unrealistic. To get a smooth group growth curve, a vari-
ance of 10% is introduced to the typical age, which means
each individual agent has a different typical age that obeys a
probabilistic distribution. After then initialisation, the Sim-
ulation World enters the loop for the desired number of time
steps. In each loop iteration, the simulation not only main-
tains the physical aspects of agents, but also governs agents
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Fig. 15 Left: Ki67 expression in colorectal carcinoma tissue microar-
ray data. Right: cell outlines and activity levels automatically identified
from the previous image using Definiens.
in switching their cell cycle state according to age. Also if
an agent is in the Growing state, the Simulation World in-
creases the size of the agent in each loop.
We introduce a probability of cell division to the simu-
lation, which is a real number between 0 and 1. The prob-
ability of cell division represents the chance that one single
agent divides at the end of its cycle: the maximum value is
which means the agent will certainly divide; the minimum
value is which means the agent will certainly die. The higher
the value, the more likely it is that the agent will divide. In
the model we use the probability of cell division to control
the modelled cell fate such that each time an agent reaches
its typical age, a random real number between 0.0 and 1.0 is
generated: if this value is smaller than the probability of cell
division value, the agent will be duplicated to represent cell
division; otherwise the agent will undergo programmed cell
death. If an agent is in a dividing state, the Simulation World
duplicates it and resets the size and age of both agents; if an
agent dies, the Simulation World removes that agent.
Similar to Model 1, the Simulation World also writes out
the geometry information of all the agents regularly; it also
records summary information including the agent popula-
tion, for ease of visualisation.
3.6 Results Model
In our goal system of spheroids, we are primarily interested
in the shape of spatial structures that tumour cells can form.
Fig. 15 shows the complexity of spatial structures in real
tissue and spheroid systems seek to replicate some of this
complexity. We can expect cell density changes across a
slice through the spheroid. Typically as hypoxic effects are
stronger towards the centre of spheroids, the cell density in
the centre part should be lower than the cell density near the
surface of the spheroid.
We are also interested in the overall shape of the spheroid.
There are existing image analysis tools that can be used for
this. We will use them to extract information from wet-lab
experimental imagery, including the position and direction
of all the cells. We will then have directly compatible data
from both wet-lab experiments and our simulation that can
be analysed using a consistent approach. With this informa-
tion we may use methods such as fractal geometry (Sav-
age et al, 2013) to analyse the overall structure of both ex-
perimental and simulation data. Based on our experience
with our physical model, we expect to be able to obtain rea-
sonably good correspondence for those data obtained from
growth experiments on substrate – but we suspect that ex-
tending the spatial interactions into three dimensions will
require further elaboration of the model.
As a preliminary step to modelling spheroid dynamics
we have developed an in vitro Petri dish system that allows
us to monitor cell populations almost continuously. We use
this system here to study population dynamics of cells under
different experimental regimes: control, therapeutic drug ac-
tion, hypoxic conditions (simulated with additional drug ac-
tion) and therapeutic drug action in hypoxic conditions. The
Petri dish lacks some of the realism of the spheroid structure
but allows us to calibrate our model against a more substan-
tial data set than we could feasibly derive from a spheroid.
In subsequent work we will then re-fit this calibrated model
to account for spheroid conditions and especially hypoxia;
our studies in artificially introduced hypoxic conditions will
make a valuable contribution to the model fitting we must
ultimately undertake with limited data.
Initially we consider the broad-scale dynamics of the
cell population, i.e. population growth. The change of cell
population can be represented by a population growth curve,
with time on the x-axis and number of cells on the y-axis. By
comparing the shape of two growth curves, we are able to
compare population dynamics in in vitro experiments with
in silico results. This allows us to focus on our cell cycle
model parameters alone, i.e. the state transition probabili-
ties. In our next analysis, and in a subsequent publication,
we will carry out analysis of the spatial patterning of cells
over time in order to determine parameter values for the
strength of cell-cell interactions.
3.7 Summary
To summarise, a number of assumptions from Model 1 still
hold:
– Only contact force, adhesion force and resistance force
are significant (Domain).
– Cells can be implemented as ellipsoids (Platform Model).
– Matter is evenly distributed within a cell (Platform Model).
– Contact force can be computed using the Perram-Wertheim
approach (Platform Model).
– Adhesion force can be modelled as a step function on
distance (i.e. the growth factor gradient does not have a
significant effect on attractive force) (Platform Model).
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– Contact and adhesion forces balance at a defined point
when cells are in contact, and the strengths of the forces
can be calibrated based on this (Platform Model).
– Cells move at very low speed so their acceleration ap-
proaches zero and the forces upon them are balanced
(Platform Model).
– Resistance force can be computed using Stokes’ law,
and the known properties of the fluid medium (Platform
Model) (Platform Model).
– Interactions with the substrate can be modelled as inter-
actions with mirrored agents (Platform Model).
Other assumptions no longer hold:
– Cell size and shape do change during the experiment
(Domain Model). In our in vitro data it is clear that cell
size and shape changes as cells progress through the cell
cycle – we must accommodate this.
– Cells may divide or die during the timeframe of our ex-
periment (Domain Model). We are modelling behaviour
over much longer time frames and so need to account for
the cell life cycle and cell death.
In addition to these two changes, the only other substan-
tial change is the need to amend the implementation of the
detailed calculations of interaction potentials and their re-
sulting forces and torques, since these must now take changes
to cell size and shape into account.
4 2D Growth Experiment and Model Calibration
Now we have a framework in place that allows us to reuse
the physical model within new research contexts, the next
step is to use it along with wet-lab experimentation to cali-
brate it. In the following sections, we report on experimental
set up and on model calibration, and then discuss the prob-
lems arising.
4.1 Cell Line and Experiment
We designed and implemented four Petri-dish growth ex-
periments using the HCT-116 cell line. HCT-116 cells are
human colorectal cancer cells carrying the wildtype TP53
gene and with intrinsic metastatic capacity (Céspedes et al,
2007); they are very suitable for 2D (monolayer) and 3D
(spheroids) culture models. The cell line also harbours wild-
type homozygous thymidylate synthetase gene (a key en-
zyme in DNA synthesis) but with reduced stability of both
the transcriptional and translational products that may im-
pair the response of HCT-116 cells to 5-FU. Further, the
HCT-116 cells have wildtype thymidine phosphorylase (one
of the enzymes system for the anabolic activation of 5-FU)
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Fig. 17 Population count of HCT-116 cells in in vitro growth experi-
ment (Sect. 4.1), measured at 24 h intervals under four different treat-
ment conditions. Bars from left to right: with no treatment; with only
5-FU; with only hypoxia; with both 5-FU and hypoxia. (Note logarith-
mic Y scale.)
and a low level expression mutant dihydropyrimidine dehy-
drogenase gene (a major enzyme for the catabolic inactiva-
tion of 5-FU).
The cells are planted in a glass bottom-flat well, 96-
well tissue culture plate and left to grow for 120 h, with no
treatment, 5-FU, hypoxia, and the combination of 5-FU and
hypoxia, respectively. Each experiment starts with 20,000
cells, and the total number of cells in the population is mea-
sured every 24 h. In addition to the population count, we also
took time-lapse photographs of the same area of the well ev-
ery 10 min for the first 20 h (Fig. 16).
As a first step towards modelling the cells’ spatial dis-
tribution, we need to simulate the cell population dynamics,
i.e. the shape of the population growth curve. Several initial
experiments were conducted to determine appropriate drug
doses for experimentation. A large-scale in vitro growth ex-
periment was then repeated three times under each of the
four conditions; the results are shown in Fig. 17. This mix of
different experimental conditions and replicates is sufficient
to demonstrate plausible model calibration for our purposes.
Fig. 17 shows that in all four experiments the cell popu-
lation decreases in the first 24 h; then for the control group
and 5-FU group the cell population increases quickly. In
the hypoxic condition, the cell population continues to de-
crease until 48 h after treatment, then increases until 72 h but
decreases thereafter. With the combined 5-FU and hypoxic
regime, the cell population decreases for the first 24 h, then
slightly increases for another 24 h and then decreases after
that.
The time-lapse images are processed by CellProfiler (Car-
penter et al, 2006) to find the outlines of each cell, giving
not just the population over time, but also the positions and
computed velocities of all the cells for the first 20 h. Based
upon this data, we can estimate the typical time it takes for a
cell to divide in this experimental setting, i.e. the cell cycle
length, to be approximately 12 h.
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Fig. 16 Time-lapse images of HCT-116 cell growth under only 5-FU treatment conditions (Sect. 4.1), taken at starting point, 10 h and 20 h after
planting
4.2 Control Experiment Population Growth Curve
Our first step is to build a model that predicts the growth
curve with neither 5-FU nor hypoxia. Note that during the
experiment we sample the cell population five times at an in-
terval of 24 h and take time-lapse photographs every 10 min;
these time-lapse images cover only a small fraction of the
cell population and so cannot be used to estimate total num-
ber of cells. As we do not know the changes in the total
number of cells within each 24 h interval, we assume the
population growth rate within every 24 h is constant. The
population growth rate represents the increase or decrease
in cell population over a certain period of time: the value of
the growth rate can be positive or negative.
Given the cell population at 0 h and 24 h, we can calcu-
late the growth rate during this time with
N0eµt = Nt (2)
in which N0 is the cell population at the starting time, Nt is
cell population after time t, t is doubling time, and µ is the
growth rate.
For a single cell, as stated in Sect. 3.4, we introduce
the probability of cell division which is a real number be-
tween 0.0 (do not divide and so die) and 1.0 (always divide).
From the experimental data we can calculate the population
growth rate which is in the range [−1,1]; for the model we
require the probability of cell division. Thus a conversion is
required: r represents the probability of cell division, and µ
represents the growth rate:
r =
µ +1
2
(3)
To reflect the growth condition between the sampling
points, we calculate five sets of growth parameters, shown
in Table 1, and the corresponding growth curve in Fig. 18.
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Fig. 18 Control group growth curve comparison before calibration,
showing cell population measured at 24 h intervals. White bars: sim-
ulated cells. Grey bars: HCT-116 cells in in vitro growth experiment
(Sect. 4.1), with no treatment.
4.3 Growth Curve Calibration
From Fig. 18, it is clear that the simulated population grows
much more slowly than the experimental population. One
possible source of error in our fitting is that our calculation
depends on a constant doubling time – however, the dou-
bling time may be affected by the environment, and changes
over time in the experiment. From further simulation, we
also know that simply increasing the maximum cell age pa-
rameter in the model cannot solve the problem.
In order to solve it, we have to avoid using a doubling
time. From our definition of growth rate, we know that we
only need cell population to be measured at two time points
to find the average growth rate during the interval, which
is independent of doubling time. Assuming the cell cycle is
12 h (as estimated from the time-lapse photography), which
means that each measured value from the experiment con-
tains two cycles, let x be the average growth rate during ev-
ery 24 h, N0 be the starting number, and Nt be the number at
arbitrary time. Between time N0 and N1 there should be a N′0
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Fig. 19 Control group growth curve comparison after calibration,
showing cell population measured at 24 h intervals. White bars: sim-
ulated cells. Grey bars: HCT-116 cells in in vitro growth experiment
(Sect. 4.1), with no treatment.
that satisfies{
N0 · x ·2 = N′0
N′0 · x ·2 = N1
(4)
Solving the equation we find:
x =
√
N1
4N0
(5)
In this way we find a new set of growth rate and probability
of cell division, which are shown in Table 2 – note that they
are larger values than in Table 1. They produce the growth
curve in Fig. 19.
Fig. 19 shows that the simulated cell population curve
is a good fit, both in values and shape, to the experimental
results – although the simulated results are always slightly
higher than the experimental results. This baseline model
can now be extended for further in silico experimentation.
4.4 Growth Curve with 5-FU
Instead of calculating a new value for probability of cell di-
vision from the 5-FU experiment data, we have chosen in-
stead to model 5-FU action by the introduction of a plausible
mechanism for 5-FU action – cell cycle arrest (Choudhary
et al, 2012) – while otherwise keeping the model parameters
the same as for the control group.
As we focus on the total number of the cells, we mainly
study 5-FU’s effect on cell growth rate. We add a new state
to the state machine previously shown in Fig. 14: Arrested,
as Fig. 20 shows. We do not change the growth rate or proba-
bility of cell division directly; instead, in the fate-determination
phase, those cells that decide to divide are given a probabil-
ity of entering the Arrested state. Arrested cells will not di-
vide; instead, they die after a certain time. If the probability
of arrest is too high, the total cell population will decrease,
Dividing
Idle
die
Arrested Growing
die
Fig. 20 5-FU model: cell cycle, shown as a state diagram
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Fig. 21 5-FU group growth curve comparison after calibration, show-
ing cell population measured at 24 h intervals. White bars: simu-
lated cells. Grey bars: HCT-116 cells in in vitro growth experiment
(Sect. 4.1), with only 5-FU treatment.
and if it is too low the growth curve will look like the control
growth curve. We determined a good fit when the probability
of arrest is set to the constant value of 5% (Fig. 21).
4.5 Growth Curve with Hypoxia
Next we consider hypoxia. The establishment, development,
maintenance and progression of tumours creates unfavour-
able tumour microenvironments where the supply of oxy-
gen and nutrients to cancer cells becomes very limiting and
challenging. In response cancer cells learn to adapt (intrin-
sic and acquired) to these forms of environmental stress by
putting in place signals and triggered responses to sustain
hypoxic life (hypoxia). Tumour hypoxia is now a recog-
nised major driving factor for malignant progression and
adverse prognostic marker among cancer patients. In either
preclinical or clinical studies hypoxia has been implicated
with poor response to both chemotherapy and radiotherapy.
The hypoxia response pathway is governed by a family of
hypoxia-inducible transcription factors (HIFs) that coordi-
nate the adaptive response to hypoxia. HIF-1 is the most
characterised family member, where two amino acid residues
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(Pro402 and Pro564) in the HIF-1α subunit are subject to
oxygen-dependent hydroxylation in the cytosol by prolyl hy-
droxylase (PHD). This modification renders HIF-1α amen-
able to outright ubiquitination by the von Hippel Lindau
(pVHL) tumour suppressor protein and degradation by the
26S proteasome. Under hypoxic conditions, however, PHD
function is compromised and HIF-1α escapes ubiquitina-
tion, accumulates in the cell and translocates to the nucleus,
where it heterodimerises with HIF-1β and occupies hypoxia
response elements (HREs) of the key genes in cellular pro-
liferation, survival, energy metabolism, angiogenesis, inva-
sion and metastasis to activate and up-regulate their tran-
scription. Thus considerable efforts have lately focused on
the modulation of HIF-1α to strategically inhibit tumour growth
and development (including invasion and metastasis) and
also to sensitise tumours to chemotherapeutic agents like 5-
FU (Yoshikawa et al, 2001; Céspedes et al, 2007; Choudhary
et al, 2012).
We consider the effect of hypoxia as reduced probabil-
ity of cell division. Thus to introduce a hypoxic effect in
the model we need to reduce the probability of cell divi-
sion in all five phases. We assume that cells are affected
equally during the whole experiment; therefore we have to
amend the probability of cell division in the same way. As
described in Sect. 4.2, the increase in cell population re-
quires that the probability of cell division be higher than
0.5, and decrease of cell population requires that it be lower
than 0.5. From Fig. 17, we know that the value by which
we may decrease the probability of cell division is in the
range [0.1899,0.20711]. We choose the value 0.2 for sim-
plicity and conciseness, giving the new probabilities of cell
division for hypoxia affected cells shown in Table 3.
Even without simulation, we can see from the probabil-
ity of cell division that the new growth curve cannot match
the experiment during 24–48 h, because the probability is
higher than 0.5 and will cause an increasing cell population,
while the cell population decreases during this time in the
experiment. We cannot account for this with a homogeneous
population; we need to introduce a degree of heterogeneity
into the model, and cell heterogeneity leading to differen-
tial responses to drug action and environment conditions is
a recognised phenomenon (Bown et al, 2012).
We introduce heterogeneity in a minimal way, by assum-
ing that the hypoxia also affects the cell cycle: we introduce
a second type of cell into the model. The original cell type
(Type 1) maintains the existing cycle length, but has an in-
creased probability of cell division; the new cell type (Type
2) has a longer cell cycle but uses the original probability
of cell division, shown in Table 2. By tuning the cell cycle
length of Type 2, and adjusting the proportion of these two
types, we are able to delay the time at which the cell popula-
tion begins to increase. Table 4 shows the probability of cell
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Fig. 22 Hypoxia group growth curve comparison after calibration,
showing cell population measured at 24 h intervals. White bars: sim-
ulated cells, with the cell cycle length set to 12 h for Type 1 cells and
24 h for Type 2 cells. Grey bars: HCT-116 cells in in vitro growth ex-
periment (Sect. 4.1), with only hypoxia treatment.
division settings we are using; Fig. 22 shows the resulting
growth curve.
We can see from Fig. 22 that, although for most time
points the simulated cell population level is close to the ex-
perimental results, it is still much larger than the experimen-
tal observation at the 48 h (Day 2) point. As all the prob-
ability of cell division values must be altered equally, to
solve the problem all the values should be decreased until
the value for 24–48 h is lower than 0.5, which will make the
probability of cell division for 0–24 h lower than zero and
out of its possible range, and this means that this problem
cannot be solved by tuning the probability of cell division.
A possible solution to this fitting problem is to tune the
cycle length of the new cell type, until it remains in its first
three cycles between 24 and 48 h. As the old cell type is
in 4th-6th cycle during that time, the combination of prob-
ability of cell division of both types may fit the simulation
growth curve to the experimental one. This requires further
work to determine the proper cycle length and proportion of
the two types.
4.6 Growth Curve with Combination of 5-FU and Hypoxia
To independently test our modelling approach used to repre-
sent 5-FU and hypoxia mechanisms separately, we consider
them acting together in the model and compare the simula-
tion output with the experiment. This means that we keep
the two types of cells and their cell cycle and probability
of cell division setting with which we simulate the effect of
hypoxia, combined with the probability of cell cycle arrest
which is used in the 5-FU affected simulation. There is no
new mechanism added and no data from experiment of com-
bination of 5-FU and hypoxia is used for model calibration.
Fig. 23 shows good agreement between simulated and
experimental results, where with no other model adjustment
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Fig. 23 Combined 5-FU/hypoxia group growth curve comparison after
calibration, showing cell population measured at 24 h intervals. White
bars: simulated cells. Grey bars: HCT-116 cells in in vitro growth ex-
periment (Sect. 4.1), with combined 5-FU and hypoxia treatment.
we are able to predict periods of population growth and de-
cline. We note some differences in the rates of decline and
increase in the earlier stages of the simulation. According
to previous simulation results, this difference is most likely
driven by the hypoxia effect, because the 5-FU simulation
tends to have similar dynamics over all time points, while
the hypoxia simulation has higher variability during the pe-
riod of most difference in Fig. 23. We can see that the com-
bined effects show a reasonably good fit to the experimental
results, and we have reason to believe that, by improving
the fit of the hypoxia simulation, we are able to improve the
combined simulation at the same time.
5 Conclusion
Through initial analysis guided by the CoSMoS project struc-
ture, we have identified that the physical aspects of the new
domain do indeed have considerable similarities with those
of the original domain – so reuse of the physical model
should be appropriate, provided that the assumptions in the
model – which we have explicitly identified – are re-evaluated
appropriately within the new context.
Other aspects of the two domains are substantially dif-
ferent; for example, the cancer simulation requires an imple-
mentation of the cell cycle in order to accurately simulate the
effects of different treatments and environmental conditions,
whereas this was unnecessary in the vascular simulation ow-
ing to the initial stage limitation.
We have also identified the gaps in our knowledge about
the domain, necessary to appropriately calibrate the physical
model, which are now being filled by wet-lab experimenta-
tion. This gives us confidence that we are asking the right
questions when conducting experiments in support of cali-
bration.
What we have ended up with is emphatically not “a CoS-
MoS project” – we have simply made use of a few aspects of
CoSMoS to structure our thinking about model reuse. Step-
ney (2012) considers CoSMoS as based upon a pattern lan-
guage that should be tailored to meet the needs of the project
to which it is being applied. Moreover, Stepney (2012) notes
that CoSMoS may be applied to some phases of a project,
provided that the impact of the assumptions made during
other key phases is properly understood. In line with this
view, we have only made use of some of the large-scale
CoSMoS patterns that describe concepts such as “domain
model”, and that in a rather sketchy and informal way – but
we feel that even this first step towards CoSMoS has been
valuable in terms of forcing us to think in a principled way
about our existing work. As this work continues, we intend
to make increased use of CoSMoS techniques; for exam-
ple, to more effectively structure our interactions with do-
main experts during the calibration of the spheroid model.
We feel, in general, that the ability to adopt patterns as ap-
propriate is a significant strength of the CoSMoS approach
in terms of adoption by existing projects – as it is for other
pattern languages.
While it is important to emphasise that this project is still
work in progress, we feel that we have achieved a satisfac-
tory degree of model and software reuse – and, more impor-
tantly, we are confident that this reuse has been achieved in
a way that is appropriate and useful within our new research
context. In the future, we would like to consider strategies
and patterns for this kind of reuse within the CoSMoS pro-
cess – in particular, how a validity argument might be con-
structed and updated as a model is reused.
In addition, by documenting this process, we have a frame-
work in place that would allow us to reuse the physical model
within new research contexts in future projects. This frame-
work has been used in conjunction with experimental results
that are based on a clinically relevant cell line – HCT-116 –
and the cell line’s response to both 5-FU drug action and hy-
poxia. We fitted the model to data from a control condition,
and then added in biologically plausible mechanisms for
both drug action and hypoxia. We tested the model against
independently measured data from the combination of 5-FU
and hypoxia. In all cases we had good agreement between
experimental and simulated growth population curves.
These results are a first step to modelling cell responses
to environmental perturbations. Our modelling approach rep-
resents cells as individual agents with a cell cycle and each
cell may have its own transition probabilities between the
states in that cell cycle. Fitting to 5-FU required us to amend
the cell cycle probabilities. Fitting to hypoxia required us to
construct heterogeneous populations of cells. In each case
we were able to interpret model changes in terms of the un-
derlying biology and in this way propose mechanisms of ac-
tion. Such mechanisms could ultimately be tested through
further experimentation.
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We also believe that the model is ready to be used for
further study. Our next step will be to attempt to reproduce,
in our 2D model, the spatial distribution of cells seen in ex-
periments, using for calibration the data derived from time-
lapse images of experiments. The radial distribution func-
tion mentioned in Sect. 2.6 will continue to be used as a
quantitative measure when comparing experimental and sim-
ulated results. During adaptation of our model, we have iden-
tified four key parameters that affect the shape of the radial
distribution function curve, and will calibrate these to match
the experimental results. The calibrated model will then be
used to improve our understanding of the effects of drugs
and hypoxic conditions upon cancer cells through the im-
plementation of hypothesised mechanisms for these effects
within the low-level agents in the model.
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Table 1 Growth parameters determined for untreated cells
Hours 0–24 24–48 48–72 72–96 96–120
Growth rate (µ) -0.1525 0.656 0.3465 0.322 0.211
Probability of cell division (r) 0.42375 0.828 0.67325 0.661 0.6055
Table 2 Corrected growth parameters after calibration
Hours 0–24 24–48 48–72 72–96 96–120
Growth rate (µ) -0.1416 0.92724 0.41422 0.3798 0.23502
Probability of cell division (r) 0.42920 0.96362 0.70711 0.68990 0.61751
Table 3 Cell division probabilities for hypoxic cells
Hours 0–24 24–48 48–72 72–96 96–120
Original probability of cell division (r) 0.42920 0.96362 0.70711 0.68990 0.61751
New probability of cell division (r′) 0.22920 0.76362 0.50711 0.48990 0.41751
Table 4 Cell division probabilities for two-population hypoxia model
Hours 0–24 24–48 48–72 72–96 96–120
Probability of Type 1 cell division (r1) 0.22920 0.76362 0.50711 0.48990 0.41751
Probability of Type 2 cell division (r2) 0.32920 0.86362 0.60711 0.58990 0.51751
